spacer
Not Logged in You are not logged in
 
  News & Events > Senior Outreach Services > Announcements
Search

 

Eservice Portal
RSS FEEDS
SUBSCRIBE VIA RSS FEED
Entire Site Rss  Video
WHAT ARE RSS FEEDS?

Novo Nordisk termination w/PAAD & Senior Gold Added ›06/18/2009 8:38:40 AM
 

I am not sure if you received this information. Can this be posted on the bulletin board?

Zulma

 

-----Original Message-----
From: John.Siwczak@doh.state.nj.us [mailto:John.Siwczak@doh.state.nj.us]
Sent:
Monday, June 15, 2009 11:26 AM
Subject: Important Message from PAAD Regarding Novo Nordisk

 


Please be advised that the pharmaceutical company Novo Nordisk has terminated there contract with New Jersey's PAAD & Senior Gold Programs.  Therefore PAAD and Senior Gold will NOT pay towards the costs of any medication made by this company.  Novo Nordisk primarily makes diabetic medications (insulins), hormone replacement therapies, and haemophilia treatments.

PAAD and Senior Gold beneficiaries who currently take medications made by Novo Nordisk have the following options:
1. Pay the Part D plan's copay for the medication.
2. Contact their doctor to switch to a similar medication made by a different pharmaceutical company

In addition to the above, PAAD office is asking beneficiaries to contact Novo Nordisk at 1-800-727-6500 option 2 to urge them to continue with the NJ PAAD and Senior Gold programs.